Ovarian Cancer Trial, Recruiting NCT06633120 Sponsor: Colorado Center for Reproductive Medicine Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT06633120
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman who is having difficulty getting pregnant and have been diagnosed with PCOS (polycystic ovary syndrome) or polycystic ovaries, or you are a woman who has difficulty getting pregnant but has a good supply of eggs
  • You have a high number of small, early-stage follicles (fluid-filled sacs in the ovaries) — specifically more than 24 (confirm with trial site)
  • Your AMH level (a blood test that measures egg supply) is above 3.5 ng/ml
  • Your Body Mass Index (BMI), a measure of body weight relative to height, is below 35
  • You are willing to have your embryos tested using a genetic screening process called PGT
  • You plan to have an embryo transferred to your womb within 4 months of completing the treatment cycle in this trial
  • The male partner or sperm donor providing sperm is under 45 years old, the sperm is collected by ejaculation (including previously frozen partner or donor sperm), and the sperm meets certain quality standards for shape, movement, and count (confirm with trial site)

Who may not be able to join:

  • You have already had more than 2 IVF cycles that were unsuccessful

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 303-788-8300

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Colorado Center for Reproductive Medicine
Registry
ClinicalTrials.gov
Start date
3 February 2023
Est. completion
31 July 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Oocyte maturation; Embryo fertilization and development; Pregnancy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov